Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Maintains Target Price $5

Moomoo NewsJan 8 09:31 ET · Ratings

A Quick Look at Today's Ratings for Acelyrin(SLRN.US), With a Forecast Between $5 to $20

Moomoo NewsJan 8 08:00 ET · Ratings

Cautious Hold Rating for ACELYRIN, INC. Amid Uncertainties in Lonigutamab's Efficacy and Dosing

TipRanksJan 8 05:48 ET · Ratings

ACELYRIN Is Maintained at Neutral by Citigroup

Dow JonesJan 7 15:09 ET · Ratings

Citigroup Maintains Neutral on Acelyrin, Lowers Price Target to $3

BenzingaJan 7 14:58 ET · Ratings

Nasdaq Down 1.5%; RPM Posts Upbeat Results

BenzingaJan 7 12:05 ET